{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:41:20Z","timestamp":1787010080431,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":945,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1097\/jto.0b013e318287c224","type":"journal-article","created":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T02:26:55Z","timestamp":1362104815000},"page":"644-653","source":"Crossref","is-referenced-by-count":24,"title":["Reduced Folate Carrier and Folylpolyglutamate Synthetase, but not Thymidylate Synthase Predict Survival in Pemetrexed-Treated Patients Suffering from Malignant Pleural Mesothelioma"],"prefix":"10.1016","volume":"8","author":[{"given":"Fabian","family":"Mairinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Vollbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Halbwedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Hatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Stacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"G\u00fclly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Quehenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susann","family":"Stephan-Falkenau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kollmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mairinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Popper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e318287c224_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/TCRM.S1603","article-title":"Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma","volume":"4","author":"Goudar","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1097\/JTO.0b013e318287c224_bib2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/thorax.58.3.198","article-title":"Regulation of matrix metalloprotease activity in malignant mesothelioma cell lines by growth factors","volume":"58","author":"Liu","year":"2003","journal-title":"Thorax"},{"key":"10.1097\/JTO.0b013e318287c224_bib3","first-page":"313","article-title":"Clinical presentation and natural history of benign and malignant mesothelioma","volume":"8","author":"Antman","year":"1981","journal-title":"Semin Oncol"},{"key":"10.1097\/JTO.0b013e318287c224_bib4","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1158\/1078-0432.982.11.3","article-title":"Pemetrexed in malignant pleural mesothelioma","volume":"11","author":"Hazarika","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e318287c224_bib5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/oem.2003.010165","article-title":"Changing trends in US mesothelioma incidence","volume":"61","author":"Weill","year":"2004","journal-title":"Occup Environ Med"},{"key":"10.1097\/JTO.0b013e318287c224_bib6","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/cncr.22552","article-title":"Update on the molecular biology of malignant mesothelioma","volume":"109","author":"Lee","year":"2007","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e318287c224_bib7","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1378\/chest.123.2.551","article-title":"Surgical treatment of malignant pleural mesothelioma: a review","volume":"123","author":"van Ruth","year":"2003","journal-title":"Chest"},{"key":"10.1097\/JTO.0b013e318287c224_bib8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3816\/CLC.2009.n.014","article-title":"Malignant pleural mesothelioma: medical treatment update","volume":"10","author":"Vorobiof","year":"2009","journal-title":"Clin Lung Cancer"},{"issue":"4 Suppl","key":"10.1097\/JTO.0b013e318287c224_bib9","doi-asserted-by":"crossref","first-page":"373S","DOI":"10.1378\/chest.103.4_Supplement.373S","article-title":"Natural history and epidemiology of malignant mesothelioma","volume":"103","author":"Antman","year":"1993","journal-title":"Chest"},{"key":"10.1097\/JTO.0b013e318287c224_bib10","first-page":"2263","article-title":"Cigarette smoking, asbestos exposure, and malignant mesothelioma","volume":"51","author":"Muscat","year":"1991","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e318287c224_bib11","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1378\/chest.08-2665","article-title":"Malignant pleural mesothelioma: an update on biomarkers and treatment","volume":"136","author":"Ray","year":"2009","journal-title":"Chest"},{"key":"10.1097\/JTO.0b013e318287c224_bib12","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1200\/JCO.2006.09.0936","article-title":"Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma","volume":"25","author":"Hodgson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318287c224_bib13","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/JTO.0b013e3181834f66","article-title":"Recent advances in the treatment of malignant pleural mesothelioma","volume":"3","author":"Ramalingam","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e318287c224_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bjc.6604442","article-title":"Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials","volume":"99","author":"Ceresoli","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1097\/JTO.0b013e318287c224_bib15","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1200\/JCO.2005.04.3190","article-title":"Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma","volume":"24","author":"Ceresoli","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318287c224_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11864-008-0071-3","article-title":"Systemic treatments for mesothelioma: standard and novel","volume":"9","author":"Kindler","year":"2008","journal-title":"Curr Treat Options Oncol"},{"key":"10.1097\/JTO.0b013e318287c224_bib17","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/cncr.22208","article-title":"Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase","volume":"107","author":"Ceppi","year":"2006","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e318287c224_bib18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.lungcan.2009.12.002","article-title":"The efficacy of pemetrexed as a third- or fourth-line therapy and the significance of thymidylate synthase expression in patients with advanced non-small cell lung cancer","volume":"69","author":"Chang","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e318287c224_bib19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.lungcan.2011.01.024","article-title":"Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: the association with treatment efficacy of pemetrexed","volume":"74","author":"Chen","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e318287c224_bib20","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/JTO.0b013e318260deaa","article-title":"Folylpoly-glutamate synthetase expression is associated with tumor response and outcome from pemetrexed-based chemotherapy in malignant pleural mesothelioma","volume":"7","author":"Christoph","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e318287c224_bib21","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1200\/JCO.2009.25.9275","article-title":"Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with pemetrexed-based chemotherapy","volume":"28","author":"Righi","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318287c224_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.lungcan.2004.01.015","article-title":"Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in tumor tissues and the efficacy of 5-fluorouracil in patients with non-small-cell lung cancer","volume":"45","author":"Shintani","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e318287c224_bib23","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/JTO.0b013e3182208ea8","article-title":"Significance of thymidylate synthase and thyroid transcription factor 1 expression in patients with nonsquamous non-small cell lung cancer treated with pemetrexed-based chemotherapy","volume":"6","author":"Sun","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e318287c224_bib24","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1158\/1078-0432.CCR-10-2873","article-title":"Thymidylate synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed\/carboplatin","volume":"17","author":"Zucali","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"6C","key":"10.1097\/JTO.0b013e318287c224_bib25","first-page":"5621","article-title":"Thymidylate synthase levels as a therapeutic and prognostic predictor in breast cancer","volume":"19","author":"Nishimura","year":"1999","journal-title":"Anticancer Res"},{"key":"10.1097\/JTO.0b013e318287c224_bib26","first-page":"4097","article-title":"Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer","volume":"5","author":"Shiga","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e318287c224_bib27","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1200\/JCO.2001.19.23.4298","article-title":"ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy","volume":"19","author":"Shirota","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318287c224_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00001813-200201000-00009","article-title":"Implication of thymidylate synthase in the outcome of patients with invasive ductal carcinoma of the pancreas and efficacy of adjuvant chemotherapy using 5-fluorouracil or its derivatives","volume":"13","author":"Takamura","year":"2002","journal-title":"Anticancer Drugs"},{"key":"10.1097\/JTO.0b013e318287c224_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1200\/JCO.2003.05.044","article-title":"Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study","volume":"21","author":"Allegra","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318287c224_bib30","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1200\/JCO.2002.07.080","article-title":"Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer","volume":"20","author":"Allegra","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318287c224_bib31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-5002(01)00407-X","article-title":"Prognostic value of thymidylate synthase expression in patients with p-stage I adenocarcinoma of the lung","volume":"35","author":"Nakagawa","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e318287c224_bib32","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1158\/1535-7163.MCT-06-0073","article-title":"Therapeutic potential of antisense oligodeoxynucleotides to down-regulate thymidylate synthase in mesothelioma","volume":"5","author":"Flynn","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1097\/JTO.0b013e318287c224_bib33","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0026-895X(25)09776-7","article-title":"Thymidylate synthase as a determinant of 5-fluoro-2'-deoxyuridine response in human colonic tumor cell lines","volume":"34","author":"Berger","year":"1988","journal-title":"Mol Pharmacol"},{"key":"10.1097\/JTO.0b013e318287c224_bib34","doi-asserted-by":"crossref","DOI":"10.4061\/2010\/306754","article-title":"Analysis of the thymidylate synthase gene structure in colorectal cancer patients and its possible relation with the 5-Fluorouracil drug response","volume":"2010","author":"Calascibetta","year":"2010","journal-title":"J Nucleic Acids"},{"key":"10.1097\/JTO.0b013e318287c224_bib35","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0006-2952(03)00287-9","article-title":"Induction of resistance to the multitargeted antifolate Pemetrexed (ALIMTA) in WiDr human colon cancer cells is associated with thymidylate synthase overexpression","volume":"66","author":"Sigmond","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1097\/JTO.0b013e318287c224_bib36","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/sj.bjc.6604346","article-title":"Low expression of gamma-glutamyl hydrolase mRNA in primary colorectal cancer with the CpG island methylator phenotype","volume":"98","author":"Kawakami","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1097\/JTO.0b013e318287c224_bib37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10555-007-9049-z","article-title":"Molecular basis of antifolate resistance","volume":"26","author":"Assaraf","year":"2007","journal-title":"Cancer Metastasis Rev"},{"issue":"12 Pt 2","key":"10.1097\/JTO.0b013e318287c224_bib38","doi-asserted-by":"crossref","first-page":"4276s","DOI":"10.1158\/1078-0432.CCR-040010","article-title":"Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent","volume":"10","author":"Adjei","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e318287c224_bib39","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1158\/1535-7163.MCT-07-0449","article-title":"Effects of folate and folylpolyglutamyl synthase modulation on chemosensitivity of breast cancer cells","volume":"6","author":"Cho","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1097\/JTO.0b013e318287c224_bib40","doi-asserted-by":"crossref","first-page":"8772","DOI":"10.1158\/0008-5472.CAN-07-0156","article-title":"Identification and characterization of genetic variation in the folylpolyglutamate synthase gene","volume":"67","author":"Leil","year":"2007","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e318287c224_bib41","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/sj.bjc.6605501","article-title":"The role of folate receptor alpha (FRalpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy","volume":"102","author":"Nutt","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1097\/JTO.0b013e318287c224_bib42","doi-asserted-by":"crossref","first-page":"834170","DOI":"10.1155\/2011\/834170","article-title":"Impairment of methotrexate transport is common in osteosarcoma tumor samples","volume":"2011","author":"Sowers","year":"2011","journal-title":"Sarcoma"},{"key":"10.1097\/JTO.0b013e318287c224_bib43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4143\/crt.2010.42.3.163","article-title":"Influence of reduced folate carrier and dihydrofolate reductase genes on methotrexate-induced cytotoxicity","volume":"42","author":"Yoon","year":"2010","journal-title":"Cancer Res Treat"},{"key":"10.1097\/JTO.0b013e318287c224_bib44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdh059","article-title":"Modified RECIST criteria for assessment of response in malignant pleural mesothelioma","volume":"15","author":"Byrne","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1097\/JTO.0b013e318287c224_bib45","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ymeth.2009.12.006","article-title":"Why the need for qPCR publication guidelines?\u2013The case for MIQE","volume":"50","author":"Bustin","year":"2010","journal-title":"Methods"},{"key":"10.1097\/JTO.0b013e318287c224_bib46","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin Chem"},{"key":"10.1097\/JTO.0b013e318287c224_bib47","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ijc.10829","article-title":"Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines","volume":"103","author":"Liani","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1097\/JTO.0b013e318287c224_bib48","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/JTO.0b013e3182460fa9","article-title":"Detection of circulating lung cancer cells with strong thymidylate synthase reactivity in the peripheral blood of a patient with pulmonary adenocarcinoma treated with pemetrexed","volume":"7","author":"Christoph","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e318287c224_bib49","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/JTO.0b013e31824fe95a","article-title":"Thymidylate synthase protein expression by IHC and gene copy number by SISH correlate and show great variability in non-small cell lung cancer","volume":"7","author":"Wynes","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e318287c224_bib50","first-page":"299","article-title":"Influence of fixation and immunohistological technique on accuracy, precision and inter-observer reproducibility of plasma cell counting","volume":"3","author":"Bodeutsch","year":"1991","journal-title":"Anal Cell Pathol"},{"key":"10.1097\/JTO.0b013e318287c224_bib51","first-page":"922","article-title":"Heterogeneity and reproducibility of microvessel counts in breast cancer","volume":"73","author":"de Jong","year":"1995","journal-title":"Lab Invest"},{"key":"10.1097\/JTO.0b013e318287c224_bib52","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/BF01041181","article-title":"Observer variation in quantification of immunocytochemistry by image analysis","volume":"23","author":"Jagoe","year":"1991","journal-title":"Histochem J"},{"key":"10.1097\/JTO.0b013e318287c224_bib53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2377-9-13","article-title":"Significant difference between three observers in the assessment of intraepidermal nerve fiber density in skin biopsy","volume":"9","author":"W\u00f6pking","year":"2009","journal-title":"BMC Neurol"},{"key":"10.1097\/JTO.0b013e318287c224_bib54","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/10428190500051844","article-title":"Pathology Panel of the Lymphoma\/Leukemia Molecular Profiling Project. Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma","volume":"46","author":"Zu","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1097\/JTO.0b013e318287c224_bib55","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.1158\/1078-0432.CCR-11-0209","article-title":"EGFR protein expression in non-small cell lung cancer predicts response to an EGFR tyrosine kinase inhibitor\u2013a novel antibody for immunohistochemistry or AQUA technology","volume":"17","author":"Mascaux","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e318287c224_bib56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.lungcan.2010.12.004","article-title":"Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma","volume":"72","author":"Ceresoli","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e318287c224_bib57","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ctrv.2009.09.003","article-title":"Second-line treatment for malignant pleural mesothelioma","volume":"36","author":"Ceresoli","year":"2010","journal-title":"Cancer Treat Rev"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415328240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415328240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T18:26:41Z","timestamp":1745951201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415328240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1556086415328240"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e318287c224","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}